NIH signs on IDT Biologika to manufacture clinical trial supply
The NIH has contracted IDT Biologika to manufacture five E. coli master cell banks for BLA, IND, and Phase I/II trial supply.
Archives for July 16, 2019
Boehringer looks to oncology vaccines with €325m acquisition
Boehringer takes on AMAL to gain access to its cancer vaccine technology, with a lead candidate due to enter first-in-human studies this month.
‘Dead cells don’t cure cancer’: BioLife acquires cold-chain solutions
BioLife exercises its option to acquire the remaining shares of the cold chain management company, SAVSU.